Janux Therapeutics Inc (JANX)

04:01 AM

Janux Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - Business Wire

04:01 AM

Aug 05, 2025

Janux Therapeutics reaches clinical milestone in Merck TRACTr collaboration - TipRanks

Aug 05, 2025

Aug 05, 2025

Janux Therapeutics Announces Clinical Milestone Achievement in TRACTr Collaboration With Merck - Yahoo Finance

Aug 05, 2025

Aug 03, 2025

Is Janux Therapeutics Inc. a growth stock or a value stockSuperior return velocity - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What analysts say about Janux Therapeutics Inc. stockTrack top-performing stocks in real-time - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the latest earnings results for Janux Therapeutics Inc.Build wealth faster with consistent investment plans - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Janux Therapeutics Inc. stock in 2025Free Market Dynamics Reports - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives Janux Therapeutics Inc. stock priceExplosive trading growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Janux Therapeutics Inc. Stock Analysis and ForecastAchieve breakthrough gains with expert advice - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Janux Therapeutics Inc. generate profit in a changing economyMaximize your gains with professional insights - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Janux Therapeutics Inc. stock overvalued or undervaluedMaximize gains with data-driven stock picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes Janux Therapeutics Inc. stock price move sharplyAccess powerful market insights for free - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Janux Therapeutics Inc. in the next 12 monthsUnlock your portfolio’s hidden potential - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Janux Therapeutics Inc. compare to its industry peersAccelerated financial growth - Jammu Links News

Aug 03, 2025

Aug 01, 2025

Can Janux Therapeutics Inc. Regain Momentum After BreakdownReal Trader Watchlist of Hot Stocks Released - metal.it

Aug 01, 2025

Jul 31, 2025

Optimistic Buy Rating for Janux Therapeutics Driven by Strategic Pipeline and Diversification - TipRanks

Jul 31, 2025

Jul 31, 2025

Janux: A High-Risk/High-Reward Bet On Oncology And Autoimmune Therapies Backed By $1B In Cash - Seeking Alpha

Jul 31, 2025

Jul 30, 2025

Why Janux Therapeutics Inc. stock attracts strong analyst attentionTriple Return Setup With Risk Control Explained - metal.it

Jul 30, 2025

Jul 29, 2025

Janux Therapeutics Receives Buy Rating from Leerink Partners Analyst Jeffrey La Rosa - AInvest

Jul 29, 2025

Jul 29, 2025

Why did JANX's operating expenses surge in Q3 2024? - AInvest

Jul 29, 2025

Jul 29, 2025

Analysts Are Bullish on These Healthcare Stocks: Ionis Pharmaceuticals (IONS), Janux Therapeutics Inc (JANX) - The Globe and Mail

Jul 29, 2025

Jul 28, 2025

Analysts Praise Ionis Pharmaceuticals and Janux Therapeutics for Bright Healthcare Futures - AInvest

Jul 28, 2025

Jul 28, 2025

JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $90 - 富途牛牛

Jul 28, 2025

Jul 28, 2025

H.C. Wainwright Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $70 - 富途牛牛

Jul 28, 2025

Jul 28, 2025

Combining machine learning predictions for Janux Therapeutics Inc. Yield Curve Outlook and Long-Term Implication Summary - metal.it

Jul 28, 2025

Jul 27, 2025

What is the dividend policy of Janux Therapeutics Inc. stockSuperior stock selection - Jammu Links News

Jul 27, 2025

Jul 25, 2025

Evercore ISI Analyst Maintains Buy Rating on Janux Therapeutics with $25.00 Price Target - AInvest

Jul 25, 2025

Jul 25, 2025

Janux Therapeutics Inc: Strategic Advancements and Strong Positioning in Oncology Drive Buy Rating - TipRanks

Jul 25, 2025

Jul 25, 2025

Adc Therapeutics Sa shares fall 1.83% after-hours following Janux Therapeutics' R&D Day press release. - AInvest

Jul 25, 2025

Jul 25, 2025

Why Intel Stock Is Plummeting Today - The Globe and Mail

Jul 25, 2025

Jul 25, 2025

What makes Janux Therapeutics Inc. stock attractive to long term investorsRapid-fire capital growth - Jammu Links News

Jul 25, 2025

Jul 25, 2025

Janux Therapeutics’ Strategic Expansion and Promising Pipeline Drive Buy Rating - TipRanks

Jul 25, 2025

Jul 25, 2025

Janux Therapeutics Faces Trade Policy Challenges: Impact on Operations and Growth - TipRanks

Jul 25, 2025

Jul 24, 2025

Innovative Preclinical Programs and Strategic Tumor Activation Drive Buy Rating for Janux Therapeutics - TipRanks

Jul 24, 2025

Jul 24, 2025

Is Janux Therapeutics Inc. stock a growth or value playHigh-profit capital plays - Jammu Links News

Jul 24, 2025